AC Immune SA - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
ACIU Nasdaq 8731 https://www.acimmune.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AC Immune SA

AC Immune to Present at Jefferies 2019 London Healthcare Conference - Nov 14th, 2019 12:00 pm
AC Immune Q3 2019 Financial Results and Business Update - Nov 13th, 2019 12:00 pm
5 Biotech Stocks Set to Beat Q3 Earnings Estimates - Nov 11th, 2019 12:50 pm
Linde (LIN) to Report Q3 Earnings: What's in the Cards? - Nov 8th, 2019 3:25 pm
AC Immune Hosts Key Opinion Leader Event: ‘Untangling’ Tau Pathology to Treat Alzheimer’s and Neurodegenerative Diseases - Nov 6th, 2019 9:05 pm
Were Hedge Funds Right About Souring On AC Immune SA (ACIU)? - Nov 6th, 2019 7:31 pm
AC Immune to Host Key Opinion Leader Event: ‘Untangling’ Tau Pathology to Treat Alzheimer’s and Neurodegenerative Diseases - Oct 24th, 2019 11:00 am
These Factors Make AC Immune SA (NASDAQ:ACIU) An Interesting Investment - Sep 25th, 2019 12:52 pm
AC Immune to Earn Milestone From Lilly for Alzheimer's Drug - Sep 23rd, 2019 5:22 pm
6 Small Drug Stocks in Focus Ahead of World Alzheimer's Day - Sep 20th, 2019 2:02 pm
AC Immune Receives First Milestone Payment from Lilly in Small Molecule Tau Morphomer™ Program - Sep 20th, 2019 11:00 am
AC Immune Receives Milestone Payment in Connection with Initiation of a Phase 2 Trial of Tau PET Tracer PI-2620 - Sep 17th, 2019 6:00 am
AC Immune Awarded Michael J. Fox Foundation Grant to Accelerate Development of Parkinson’s Disease Diagnostic Imaging Agent - Sep 4th, 2019 11:00 am
Is AC Immune (NASDAQ:ACIU) Using Too Much Debt? - Aug 19th, 2019 4:31 pm
AC Immune Reports Q2 2019 Financial Results, Business and Clinical Update - Aug 14th, 2019 11:00 am
AC Immune Announces Research Collaboration with University of Pennsylvania Focusing on Pathogenic Protein TDP-43 in Neurodegenerative Diseases - Aug 12th, 2019 11:00 am
Analysts Estimate AC Immune (ACIU) to Report a Decline in Earnings: What to Look Out for - Aug 7th, 2019 2:30 pm
AC Immune Initiates Phase I Study for Alzheimer's Disease - Jul 18th, 2019 2:26 pm
AC Immune Initiates Phase 1 Study of ACI-3024 Small Molecule Tau Morphomer™, an Investigational Treatment for Alzheimer’s Disease - Jul 17th, 2019 11:00 am
AC Immune Hosts KOL Event and Reports Initial Interim Clinical Data for ACI-24 Vaccine to Treat Alzheimer’s Disease-like Symptoms in Subjects with Down Syndrome - Jul 11th, 2019 12:00 pm